Abstract:Background: We propose a decision-referral approach for integrating artificial intelligence (AI) into the breast-cancer screening pathway, whereby the algorithm makes predictions on the basis of its quantification of uncertainty. Algorithmic assessments with high certainty are done automatically, whereas assessments with lower certainty are referred to the radiologist. This two-part AI system can triage normal mammography exams and provide post-hoc cancer detection to maintain a high degree of sensitivity. This study aimed to evaluate the performance of this AI system on sensitivity and specificity when used either as a standalone system or within a decision-referral approach, compared with the original radiologist decision. Methods: We used a retrospective dataset consisting of 1 193 197 full-field, digital mammography studies carried out between Jan 1, 2007, and Dec 31, 2020, from eight screening sites participating in the German national breast-cancer screening programme. We derived an internal-test dataset from six screening sites (1670 screen-detected cancers and 19 997 normal mammography exams), and an external-test dataset of breast cancer screening exams (2793 screen-detected cancers and 80 058 normal exams) from two additional screening sites to evaluate the performance of an AI algorithm on sensitivity and specificity when used either as a standalone system or within a decision-referral approach, compared with the original individual radiologist decision at the point-of-screen reading ahead of the consensus conference. Different configurations of the AI algorithm were evaluated. To account for the enrichment of the datasets caused by oversampling cancer cases, weights were applied to reflect the actual distribution of study types in the screening programme. Triaging performance was evaluated as the rate of exams correctly identified as normal. Sensitivity across clinically relevant subgroups, screening sites, and device manufacturers was compared between standalone AI, the radiologist, and decision referral. We present receiver operating characteristic (ROC) curves and area under the ROC (AUROC) to evaluate AI-system performance over its entire operating range. Comparison with radiologists and subgroup analysis was based on sensitivity and specificity at clinically relevant configurations. Findings: The exemplary configuration of the AI system in standalone mode achieved a sensitivity of 84·2% (95% CI 82·4-85·8) and a specificity of 89·5% (89·0-89·9) on internal-test data, and a sensitivity of 84·6% (83·3-85·9) and a specificity of 91·3% (91·1-91·5) on external-test data, but was less accurate than the average unaided radiologist. By contrast, the simulated decision-referral approach significantly improved upon radiologist sensitivity by 2·6 percentage points and specificity by 1·0 percentage points, corresponding to a triaging performance at 63·0% on the external dataset; the AUROC was 0·982 (95% CI 0·978-0·986) on the subset of studies assessed by AI, surpassing radiologist performance. The decision-referral approach also yielded significant increases in sensitivity for a number of clinically relevant subgroups, including subgroups of small lesion sizes and invasive carcinomas. Sensitivity of the decision-referral approach was consistent across the eight included screening sites and three device manufacturers. Interpretation: The decision-referral approach leverages the strengths of both the radiologist and AI, demonstrating improvements in sensitivity and specificity surpassing that of the individual radiologist and of the standalone AI system. This approach has the potential to improve the screening accuracy of radiologists, is adaptive to the requirements of screening, and could allow for the reduction of workload ahead of the consensus conference, without discarding the generalised knowledge of radiologists. Funding: Vara.

Dynamic AI-assisted Ipsilateral Tissue Matching for Digital Breast Tomosynthesis

AI-enhanced Mammography With Digital Breast Tomosynthesis for Breast Cancer Detection: Clinical Value and Comparison With Human Performance

Artificial Intelligence for Reducing Workload in Breast Cancer Screening with Digital Breast Tomosynthesis

The Transformative Power of Digital Breast Tomosynthesis and Artificial Intelligence in Breast Cancer Diagnosis

Impact of Different Mammography Systems on Artificial Intelligence Performance in Breast Cancer Screening

Prospective study of AI-assisted prediction of breast malignancies in physical health examinations: role of off-the-shelf AI software and comparison to radiologist performance

Diagnosis of architectural distortion on digital breast tomosynthesis using radiomics and deep learning

Abstract B078: Artificial-intelligence-driven breast density assessment in the transition from full-field digital mammograms to digital breast tomosynthesis

Artificial Intelligence for Breast Cancer Detection on Mammography: Factors Related to Cancer Detection

AI-based strategies in breast mass ≤ 2 cm classification with mammography and tomosynthesis

Evaluation of Combined Artificial Intelligence and Radiologist Assessment to Interpret Screening Mammograms

Evaluating the Margins of Breast Cancer Tumors by Using Digital Breast Tomosynthesis with Deep Learning: A Preliminary Assessment

AI for interpreting screening mammograms: implications for missed cancer in double reading practices and challenging-to-locate lesions

Robust breast cancer detection in mammography and digital breast tomosynthesis using an annotation-efficient deep learning approach

Preoperative Staging in Breast Cancer: Intraindividual Comparison of Unenhanced MRI Combined With Digital Breast Tomosynthesis and Dynamic Contrast Enhanced-MRI

Combining the strengths of radiologists and AI for breast cancer screening: a retrospective analysis

Automated assessment of task-based performance of digital mammography and tomosynthesis systems using an anthropomorphic breast phantom and deep learning-based scoring

Diagnostic Performance of an Artificial Intelligence System in Breast Ultrasound

Artificial intelligence in digital histopathology for predicting patient prognosis and treatment efficacy in breast cancer

Virtual clinical trial to compare cancer detection using combinations of 2D mammography, digital breast tomosynthesis and synthetic 2D imaging

Consistency of Artificial Intelligence (AI)-based Diagnostic Support Software in Short-term Digital Mammography Reimaging After Core Needle Biopsy